Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA:600436)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Pharmaceutical Manufacturing	5.81B	4.80B	3.81B	3.97B					-
Pharmaceutical Manufacturing Growth	20.91%	25.94%	-4.00%	-					-
Cosmetics Manufacturing	813.38M	706.76M	634.30M	841.35M					-
Cosmetics Manufacturing Growth	15.09%	11.42%	-24.61%	-					-
Pharmaceutical Distribution Industry	5.92B	4.20B	4.06B	3.15B					-
Pharmaceutical Distribution Industry Growth	40.89%	3.60%	29.01%	-					-
Other	270.49M	322.95M	168.63M	44.89M					-
Other Growth	-16.24%	91.51%	275.68%	-					-
Offset of Business Segment	-2.03B	-	-	-					-
Unallocated Other	-	22.31M	19.52M	17.29M					-
Unallocated Other Growth	-	14.28%	12.94%	-					-
Total	10.79B	10.06B	8.69B	8.02B					-
Total Growth	7.25%	15.69%	8.38%	-					-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
North-East Chia	-	-	-	-					21.96M
North China	-	-	-	-					76.91M
East China	-	-	-	-					1.60B
South China	-	-	-	-					253.95M
Central China	-	-	-	-					66.26M
North-West China	-	-	-	-					9.43M
South-West China	-	-	-	-					35.98M
Overseas	424.48M	457.64M	401.61M	371.91M					223.71M
Overseas Growth	-7.25%	13.95%	7.98%	-					0.35%
China	10.36B	9.60B	8.29B	7.65B					-
China Growth	7.94%	15.78%	8.40%	-					-
Total	10.79B	10.06B	8.69B	8.02B					2.28B
Total Growth	7.25%	15.69%	8.38%	-					21.82%

Source: S&P Global Market Intelligence.